| Literature DB >> 30682193 |
Piyush Gondaliya, Aishwarya Dasare, Akshay Srivastava, Kiran Kalia.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0208044.].Entities:
Year: 2019 PMID: 30682193 PMCID: PMC6347208 DOI: 10.1371/journal.pone.0211591
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 6Effect of miR29b mimics and inhibitors on expression profiles of DNMT1 in DN model.
A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT1 expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT1. Scale bar, 20 μm. Representative (n = 5), * indicates ‘p’ value <0.05, **indicates ‘p’ value < 0.01, *** indicate p value <0.001.
Fig 9miR-29b decreases fibrosis and tubular injury via downregulation of fibronectin and KIM-1.
A and B: Effect of miR29b mimics and inhibitors on expression profiles of KIM-1 and Fibronectin in DN model (n = 2), * indicates p value <0.05.
Fig 7Effect of miR29b mimics and inhibitors on expression profiles of DNMT3B in DN model.
A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT3B expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT3B. Scale bar, 20 μm. Representative (n = 5), * indicates ‘p’ value <0.05, ** indicates ‘p’ value < 0.01, *** indicate p value <0.001.
Fig 8Effect of miR-29b mimics and inhibitor on expression profile of DNMT3A in DN model.
A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT3A expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT3A. Scale bar, 18μm. Representative (n = 5), *indicates ‘p’ value <0.05, ** indicates ‘p’ value < 0.01, *** indicate p value <0.001.